This small, 50-patient trial demonstrated that there were no safety or feasibility issues with delayed reperfusion, and there was a nonsignificant trend to a reduction in infarct size (15% to 13%). 10 A larger pivotal trial to determine the efficacy of such a strategy has been recommended.
1
—
—